497 related articles for article (PubMed ID: 18715665)
21. Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence.
Wiegand J; Hasenclever D; Tillmann HL
Antivir Ther; 2008; 13(2):211-20. PubMed ID: 18505172
[TBL] [Abstract][Full Text] [Related]
22. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
[TBL] [Abstract][Full Text] [Related]
23. Genetic variability of hepatitis B virus and response to antiviral therapy.
Liu CJ; Kao JH
Antivir Ther; 2008; 13(5):613-24. PubMed ID: 18771045
[TBL] [Abstract][Full Text] [Related]
24. Sustained virologic response to treatment in 100% of patients recently infected, nosocomially, with HCV genotype 2.
Sikuler E; Tur-Kaspa R; Shemer-Avni Y; Delgado J; Zilberman D; Fich A; Baruch Y; Hyam E
J Clin Gastroenterol; 2008 Jul; 42(6):730-3. PubMed ID: 18574394
[TBL] [Abstract][Full Text] [Related]
25. Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus.
Tamori A; Hayashi T; Shinzaki M; Kobayashi S; Iwai S; Enomoto M; Morikawa H; Sakaguchi H; Shiomi S; Takemura S; Kubo S; Kawada N
J Med Virol; 2009 Jun; 81(6):1009-14. PubMed ID: 19382258
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic implications of hepatitis B virus genotypes.
Liu CJ; Kao JH; Chen DS
Liver Int; 2005 Dec; 25(6):1097-107. PubMed ID: 16343058
[TBL] [Abstract][Full Text] [Related]
27. Treatment options for patients with hepatitis C: role of pharmacists in optimizing treatment response and managing adverse events.
Smith JP
Pharmacotherapy; 2008 Sep; 28(9):1151-61. PubMed ID: 18752386
[TBL] [Abstract][Full Text] [Related]
28. Low-dose IL-2 therapy reduces HCV RNA and HBV DNA: case report.
Tomova R; Antonov K; Ivanova A; Jacobs JJ; Koten JW; Den Otter W; Krastev Z
Anticancer Res; 2009 Dec; 29(12):5241-4. PubMed ID: 20044643
[TBL] [Abstract][Full Text] [Related]
29. Predictive factors and virological response to interferon treatment in children with chronic hepatitis B.
Söderström A; Lindh M; Ekholm K; Conradi N; Horal P; Krantz M; Hultgren C; Norkrans G
Scand J Infect Dis; 2005; 37(1):40-7. PubMed ID: 15764189
[TBL] [Abstract][Full Text] [Related]
30. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
Soriano V; Barreiro P; Martín-Carbonero L; Castellares C; Ruiz-Sancho A; Labarga P; Ramos B; Gonzalez-Lahoz J
J Infect Dis; 2007 Apr; 195(8):1181-3. PubMed ID: 17357055
[TBL] [Abstract][Full Text] [Related]
31. Factors predictive of a beneficial response to therapy of hepatitis C.
Davis GL; Lau JY
Hepatology; 1997 Sep; 26(3 Suppl 1):122S-127S. PubMed ID: 9305676
[TBL] [Abstract][Full Text] [Related]
32. [Genetic diagnosis of hepatitis C virus infection].
Stańczak JJ
Pol Merkur Lekarski; 1999 Feb; 6(32):92-5. PubMed ID: 10337182
[TBL] [Abstract][Full Text] [Related]
33. Occult hepatitis B virus and hepatitis C virus infections.
Carreño V; Bartolomé J; Castillo I; Quiroga JA
Rev Med Virol; 2008; 18(3):139-57. PubMed ID: 18265423
[TBL] [Abstract][Full Text] [Related]
34. Virology of hepatitis B and C viruses and antiviral targets.
Pawlotsky JM
J Hepatol; 2006; 44(1 Suppl):S10-3. PubMed ID: 16338022
[TBL] [Abstract][Full Text] [Related]
35. Coinfection by hepatitis B virus and hepatitis C virus.
Pontisso P; Gerotto M; Benvegnù L; Chemello L; Alberti A
Antivir Ther; 1998; 3(Suppl 3):137-42. PubMed ID: 10726063
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response.
Baldick CJ; Eggers BJ; Fang J; Levine SM; Pokornowski KA; Rose RE; Yu CF; Tenney DJ; Colonno RJ
J Hepatol; 2008 Jun; 48(6):895-902. PubMed ID: 18362040
[TBL] [Abstract][Full Text] [Related]
37. [Interferon].
Tamori A; Kawada N
Nihon Rinsho; 2012 Apr; 70(4):620-4. PubMed ID: 22568143
[TBL] [Abstract][Full Text] [Related]
38. Current issues and future directions in treatment.
Hui CK; Lau GK
Semin Liver Dis; 2006 May; 26(2):192-7. PubMed ID: 16673297
[TBL] [Abstract][Full Text] [Related]
39. [Chronic hepatitis C: virologic and immunologic aspects and questions of therapy].
Pár A
Orv Hetil; 1997 Jun; 138(22 Suppl 1):1465-76. PubMed ID: 9221376
[TBL] [Abstract][Full Text] [Related]
40. [Hepatitis B and C virus mutants--clinical relevance].
Blum HE
Schweiz Rundsch Med Prax; 1994 Sep; 83(36):1000-4. PubMed ID: 7939054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
